Proton imaging of siloxanes to map tissue oxygenation levels (PISTOL): A tool for quantitative tissue oximetry

NMR in Biomedicine

Volumn 21, Issue 8, 2008, Pages 899-907

  Kodibagkar, Vikram D ^a   Wang, Xianghui ^a   Pacheco Torres, Jesüs ^a,b   Gulaka, Praveen ^a   Mason, Ralph P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Echo planar imaging (EPI); Hexamethyldisiloxane; Muscle; Oximetry; Oxygen tension; Prostate tumor; Water and fat suppression

Indexed keywords

NUCLEAR MAGNETIC RESONANCE; OXYGENATION; OXYGENATORS; SILICON COMPOUNDS;

ECHO PLANAR IMAGING (EPI); HEXAMETHYLDISILOXANE; MUSCLE; OXIMETRY; OXYGEN TENSION; PROSTATE TUMOR; WATER AND FAT SUPPRESSION;

PROTONS;

HEXAMETHYLDISILOXANE; OXYGEN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CONTROLLED STUDY; HYPEROXIA; IMAGE ANALYSIS; IN VIVO STUDY; NONHUMAN; OXIMETRY; OXYGEN SATURATION; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE TUMOR; PROTON IMAGING OF SILOXANES TO MAP TISSUE OXYGENATION LEVELS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; TISSUE OXYGENATION;

ANIMALS; MUSCLE, SKELETAL; OXIMETRY; OXYGEN; PROTONS; RATS; SILOXANES;

RATTUS;

EID: 53849124377     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1279     Document Type: Article

References (43)

1. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int. J. Radiat. Biol. 2006; 82: 699-757.
2. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J. Clin. Oncol. 2002; 20: 680-687.
3. Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, Hill RP. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother. Oncol. 2006; 80: 132-137.
4. Brizel DM, Sibly GS, Prosmitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 285-289.
5. 2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. Urology, 2002; 60: 634-639.
6. 2 tension measurements. Cancer Res. 1991; 51: 3316-3322.
7. Evans SM, Judy KD, Dunphy I, Jenkins WT, Nelson PT, Collins R, Wileyto EP, Jenkins K, Hahn SM, Stevens CW, Judkins AR, Phillips P, Geoerger B, Koch CJ. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res. 2004; 64: 1886-1892.
8. Gray L, Conger A, Ebert M, Hornsey S, Scott O. The concentration of oxygen dissolved in tissues at time of irradiation as a factor in radiotherapy. Br. J. Radiol 1953; 26: 638-648.
9. 2 measurements by electron paramagnetic resonance oximetry. Radiat. Res. 1998; 150: 549-556.
10. Bourke VA, Zhao D, Gilio J, Chang C-H, Jiang L, Hahn EW, Mason RP. Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. Int. J. Radiat. Oncol. Biol. Phys. 2007; 67: 1179-1186.
11. Zhao D, Constantinescu A, Chang C-H, Hahn EW, Mason RP. Correlation of tumor oxygen dynamics with radiation response of the Dunning prostate R3327-HI tumor. Radiat. Res. 2003; 159: 621-631.
12. Kaanders JHAM, Wijffels KIEM, Marres HAM, Ljungkvist ASE, Pop LAM, van den Hoogen FJA, de Wilde PCM, Bussink J, Raleigh JA, van der Kogel AJ. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 2002; 62: 7066-7074.
13. Howe FA, Robinson SP, McIntyre DJ, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed. 2001; 14: 497-506.
14. Baudelet C, Gallez B. Current issues in the utility of blood oxygen level dependent MRI for the assessment of modulations in tumor oxygenation. Current Medical Imaging Reviews 2005; 1: 229-243.
15. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, Lei H, Meyerand ME, Grinberg OY, Hou H, Hoopes PJ, Demidenko E, Swartz HM. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J. Magn Reson Imaging 2002; 16: 511-521.
16. Kodibagkar VD, Wang X, Mason RP. Physical principles of quantitative nuclear magnetic resonance oximetry. Front Biosci. 2008; 13: 1371-1384.
17. Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods Enzymol 2004; 386: 378-418.
18. 19F nuclear magnetic resonance methodologies for the asssessment of tumour hypoxia. Philos. Trans. R. Soc. London B Biol. Sci. 2004; 359: 987-996.
19. 1H NMR approach to quantitative tissue oximetsy using hexamethyldisiloxane. Magn. Reson. Med. 2006; 55: 743-748.
20. Haase A, Frahm J, Hanicke W, Matthaei D. H-1-Nmr chemical-shift selective (Chess) imaging. Phys. Med. Biol. 1985; 30: 341-344.
21. Hunjan S, Zhao D, Constantinescu A, Hahn EW, Antich PP, Mason RP, Tumor Oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1097-1108.
22. 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr. Med. Chem. 2005; 12: 818-848.
23. 19F NMR of perfluorocarbon. Artif. Cells Blood Substit Immobil Biotechnol 1994; 22: 1141-1153.
24. 19F echo planar NMR imaging of sequestered perfluorocarbon. J. Magn Reson Imaging 1994; 4: 595-602.
25. 19F NMR indicator of tumor oxygenation. NMR Biomed. 1996; 9: 125-134.
26. 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn. Reson. Med. 1994; 32: 88-97.
27. 19F NMR spectroscopy of hexafluorobenzene. Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 161-171.
28. 19F magnetic resonance. In Fluorine and Health, Tressaud A, Haufe G (eds). Elsevier B.V.: Amsterdam, 2008; 198-276.
29. Seiyama A, Shiga T, Maeda N. Temperature effect on oxygenation and metabolism of perfused rat hindlimb muscle. In Oxygen Transport to Tissue XII, Piiper J, Goldstick TK, Meyer M (eds). Plenum Press: New York, 1990; 541-547.
30. 2 and pH in hemorrhagic shock. Crit Care Mede 1999; 27: 1869-1877.
31. Vahidi N, Clarkson RB, Liu KJ, Norby SW, Wu M, Swartz HM. In Vivo and in vitro EPR oximetry with fusinite: a new coal-derived, particulate EPR probe. Magn. Res. Med. 1994; 31: 139-146.
32. Sostaric JZ, Pandian RP, Bratasz A, Kuppusamy P. Encapsulation of a highly sensitive EPR active oxygen probe into sonochemically prepared microspheres. J. Phys. Chem. B 2007; 111: 3298-3303.
33. Yeh KA, Biade S, Lanciano RM, Brown DQ, Fenning MC, Babb JS, Hanks GE, Chapman JD. Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33: 111-118.
34. Zhao D, Constantinescu C, Hahn EW, Mason RP. Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 744-756.
35. Zhao D, Ran S, Constantinescu A, Hahn EW, Mason RP. Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia 2003; 5: 308-318.
36. 19F NMR imaging of blood oxygenation in the brain. Magn. Reson. Med. 1988; 6: 344-352.
37. Mason RP, Antich PP, Babcock EE, Constantinescu A, Peschke P, Hahn EW. Non-invasive determination of tumor oxygen tension and local variation with growth. Int. J. Radiat. Oncol. Biol. Phys. 1994; 29: 95-103.
38. Matsumoto K, Bernardo M, Subramanian S, Choyke P, Mitchell JB, Krishna MC, Lizak MJ. MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn. Reson. Med. 2006; 56: 240-246.
39. Zaharchuk G, Busse RF, Rosenthal G, Manley GT, Glenn OA, Dillon WP. Noninvasive oxygen partial pressure measurement of human body fluids in vivo using magnetic resonance imaging. Acad Radiol 2006; 13: 1016-1024.
40. Cassidy SL, Dotti A, Kolesar GB, Dochterman LW, Meeks RG, Chevalier HJ. Hexamethyldisiloxane: a 13-week subchronic whole-body vapor inhalation toxicity study in Fischer 344 rats. Int. J. Toxicol. 2001; 20: 391-399.
41. Dobrev ID, Reddy MB, Plotzke KP, Varaprath S, McNett DA, Durham J, Andersen ME. Closed-chamber inhalation pharmacokinetic studies with hexamethyldisiloxane in the rat. Inhal. Toxicol. 2003; 15: 589-617.
42. Varaprath S, McMahon JM, Plotzke KP. Metabolites of hexamethyldisiloxane and decamethylcyclopentasiloxane in Fischer 344 rat urine: a comparison of a linear and a cyclic siloxane. Drug Metab Dispos 2003; 31: 206-214.
43. Parent RA. Acute toxicity data submissions. Int. J. Toxicol. 2000; 19: 331-373.